Skip to main content

Table 5 Outcome of HNSCC Patients According to The Combined Status of Her3 and Her3 Membranous Staining

From: Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma

Tumor markers

Total

Median OS (months)

Hazard Ratio (95% CI)

P value

Her2-/Her3-

262

36.0

1.13 (0.87-1.47)

0.342

Her2+/Her3-

91

51.0

0.70 (0.51-0.95)

0.020

Her2-/Her3+

21

25.0

1.53 (0.95-2.47)

0.074

Her2+/Her3+

13

22.0

1.48 (0.78-2.79)

0.216